Plus Therapeutics (Nasdaq: PSTV) (@plustxinc) 's Twitter Profile
Plus Therapeutics (Nasdaq: PSTV)

@plustxinc

U.S. clinical-stage pharmaceutical company developing targeted radiotherapeutics for CNS cancers - recurrent glioblastoma & leptomeningeal metastases. $PSTV

ID: 1130985137389297664

linkhttps://PlusTherapeutics.com calendar_today21-05-2019 23:54:04

628 Tweet

748 Takipçi

4,4K Takip Edilen